[Tech30 Special Mention] This Bengaluru-based startup aims to accelerate drug discovery through its AI-based p

▤ Summary

However, the industry is seeing a transformation with the application of artificial intelligence (AI) where drugs can be developed with efficacy and fewer side effects. Sarath founded AI-based drug discovery platform Bayes Labsin 2019 in Bengaluru with an initial investment of Rs 50 lakh. Bayes Labs competes with some AI drug discovery companies in North America and Europe like Atomwise, Cyclica and BenevolentAI. For companies, its SaaS platform is $1,000 per user for three months where license and partnership model charges can vary according to the deal. Bayes Labs is also in discussions with various investors to raise funds to aggressively expand its customer base.

▦ Linked Companies